​

Cyclerion Therapeutics Ownership | Who Owns Cyclerion Therapeutics?

OverviewRevenueFinancialsChart

Cyclerion Therapeutics Ownership Summary

Cyclerion Therapeutics is owned by 14.61% institutional investors, 32.73% insiders, and 52.66% retail investors. Fidelity Select Biotechnology is the top mutual fund, with 1.52% of its assets in Cyclerion Therapeutics shares.

CYCN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCyclerion Therapeutics14.61%32.73%52.66%
SectorHealthcare Stocks 279.46%10.61%-190.07%
IndustryBiotech Stocks 64.06%10.67%25.27%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202518-373,392-2.24%146.49%3-57.14%2-33.33%
Dec 31, 20241820.00%381,943-63.37%150.88%7133.33%3-25.00%
Sep 30, 202415-11.76%1,042,639-0.86%412.35%3-57.14%4100.00%
Jun 30, 20241713.33%1,051,710-1.73%412.28%740.00%2-
Mar 31, 202415-6.25%1,070,2540.07%422.30%5-2-66.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology38.31K1.52%-3.55K
Fidelity Growth Compy Commingled Pl O29.17K1.16%-
Fidelity Growth Compy Commingled Pl S29.68K1.10%298.00
Vanguard Institutional Extnd Mkt Idx Tr23.49K0.77%-
Fidelity Growth Company Fund20.56K0.76%-
LUX IM Global Medtech HX16.43K0.54%-
Fidelity Extended Market Index11.29K0.44%843.00
Fidelity Nasdaq Composite ETF13.14K0.43%-
Fidelity Growth Company K69.22K0.34%-298.00
BlackRock Extended Equity Market K3.00K0.12%-1.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 21, 2024Slate Path Capital LP-Sell$555.11K
Aug 09, 2023MCGUIRE TERRANCE-Sell$27.16
Jun 03, 2021MCGUIRE TERRANCE-Buy$289.63K
Jun 03, 2021MCGUIRE TERRANCE-Buy$10.36K
Jun 03, 2021MCGUIRE TERRANCE-Buy$10.36K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q4-1
2024 Q3--
2024 Q1--
2023 Q4--

CYCN Ownership FAQ

Who Owns Cyclerion Therapeutics?

Cyclerion Therapeutics shareholders are primarily institutional investors at 14.61%, followed by 32.73% insiders and 52.66% retail investors. The average institutional ownership in Cyclerion Therapeutics's industry, Biotech Stocks , is 64.06%, which Cyclerion Therapeutics falls below.

Does Blackrock own Cyclerion Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cyclerion Therapeutics.

Who is the top mutual fund holder of Cyclerion Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of Cyclerion Therapeutics shares, with 1.52% of its total shares outstanding invested in 38.32K Cyclerion Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools